Anc. Anigbogu et al., PERMEATION CHARACTERISTICS OF 8-METHOXYPSORALEN THROUGH HUMAN SKIN - RELEVANCE TO CLINICAL TREATMENT, Journal of Pharmacy and Pharmacology, 48(4), 1996, pp. 357-366
The permeation characteristics through human skin of 8-methoxypsoralen
(8-MOP) and its physical attributes were investigated. The log octano
l/water partition coefficient and saturated aqueous solubility of 8-MO
P at 32 degrees C were 1.98 and 55.8 mu g mL(-1) respectively. 8-MOP s
howed Fickian diffusion, with its flux being linearly related to the c
oncentration of drug in the donor solution. The permeability coefficie
nt of 8-MOP through human skin from different concentrations of aqueou
s solutions and a 2.6 mu g mL(-1) bath lotion (as used in clinics) wer
e statistically identical with mean values of 1.76 +/- 0.12 x 10(-2) a
nd 1.70 +/- 0.32 x 10(-2) cm h(-1) respectively (P greater than or equ
al to 0.05). An ethanol/water (1:1 w/v) receptor solution did not impr
ove the clearance of 8-MOP from the dermis when compared with an aqueo
us vehicle. Complete removal of the stratum corneum by tape stripping
from full-thickness membranes produced a threefold increase in the flu
x of 8-MOP thus suggesting that the main barrier to 8-MOP permeation r
esides in the stratum corneum although the aqueous epidermal and derma
l tissue provide a significant resistance to transdermal drug permeati
on. The equilibrium uptake of 8-MOP into psoriatic plaques and the 8-M
OP aqueous/plaque partition coefficient were found to be more than two
fold greater than for normal stratum corneum. The absorption of 8-MOP
from the total applied topical dose (396 mg) was assessed as similar t
o 0.25% and only 25% of an oral dose, a significant reduction in the p
ossible toxic hazard. The peak concentration of 8-MOP permeating throu
gh the skin was observed at about 35 min after limited exposure for 15
min. Our results suggest that following a 15 min bath in the drug sol
ution, there may be a need for an interval of about 20 min before pati
ents are irradiated to ensure the optimization of photosensitizer with
UVA irradiation (PUVA) therapy. Alternatively, UV irradiation could b
e applied at a lower Aux over a longer time.